Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 4, 2019
Previous Article Next Article

Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy

Author affiliations

Abstract

The tumor microenvironment (TME) provides intriguing features/indications for rational design of diverse therapeutic protocols with high tumor specificity and therapeutic efficacy. In this work, we report the introduction of the sequential catalytic concept into theranostic nanomedicine for cancer-specific therapy, which has been achieved by the construction of glucose oxidase (GOD) and Mitomycin C (MMC) co-loaded superparamagnetic iron oxide nanoparticles (designated as SMG nanocatalysts). Based on the large amounts of glucose in tumors, the GOD component in SMG catalyzes glucose to convert into hydrogen peroxide (H2O2) and gluconic acid with the simultaneous consumption of oxygen. The post-produced H2O2 is further catalyzed by iron oxide in SMG to produce large amounts of highly toxic hydroxyl radicals for cancer therapy, and the generated gluconic acid enhances such a Fenton-based catalytic reaction. On the other hand, the loaded MMC drug is activated because of the consumption of oxygen and enhanced hypoxia in tumors, causing high chemotherapeutic efficacy. Based on the high synergistic chemodrug and chemodynamic therapeutic efficacy in combating cancer, cancer cells are efficiently killed and tumor growth is thus significantly suppressed. This work paves a new way for cancer therapy by taking into account the full features and advantages of the TME and the physiochemical properties of the chosen nanocatalysts, which also links nanocatalytic science and nanomedicine for proposing new efficient tumor-therapeutic modalities.

Graphical abstract: Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy

Back to tab navigation

Supplementary files

Article information


Submitted
09 Jan 2019
Accepted
20 Feb 2019
First published
20 Feb 2019

Nanoscale Horiz., 2019,4, 890-901
Article type
Communication

Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy

R. Liang, Y. Chen, M. Huo, J. Zhang and Y. Li, Nanoscale Horiz., 2019, 4, 890
DOI: 10.1039/C9NH00008A

Social activity

Search articles by author

Spotlight

Advertisements